Xlife Sciences AG (XLS)

Currency in CHF
17.60
-0.20(-1.12%)
Closed·
XLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.6017.60
52 wk Range
15.7526.80
Key Statistics
Bid/Ask
17.60 / 17.60
Prev. Close
17.8
Open
17.6
Day's Range
17.6-17.6
52 wk Range
15.75-26.8
Volume
420
Average Volume (3m)
8.92K
1-Year Change
-9.2784%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XLS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
50.00
Upside
+184.09%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Xlife Sciences AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 50.00
(+184.09% Upside)

Earnings

Latest Release
Apr 28, 2026
EPS / Forecast
-3.23 / --
Revenue / Forecast
-79.01K / --
EPS Revisions
Last 90 days

XLS Income Statement

Compare XLS to Peers and Sector

Metrics to compare
XLS
Peers
Sector
Relationship
P/E Ratio
−4.7x5.2x−0.4x
PEG Ratio
0.030.040.00
Price/Book
0.4x2.1x2.6x
Price / LTM Sales
364.5x3.7x3.1x
Upside (Analyst Target)
180.9%2.8%51.8%
Fair Value Upside
Unlock−3.9%7.5%Unlock

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services. It also develops novel treatment options in specific indication areas; focuses in the areas of medical technology to develop innovative methods for diagnosing illnesses and/or patient monitoring; and deploys artificial intelligence to improve diagnostic methods and/or processes in the field of biotechnology. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
104.57K1.83%1.86M
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
5.60M98.17%99.64M
Total
5.7M100.00%101.5M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DEVK Asset Management GmbH0.79%45,000801
Monega Rohstoffe0.79%45,000801

People Also Watch

48.660
IDR
-1.14%
16.35
MIKN
+0.62%
346.10
MTXGn
-0.83%
677.20
PGHN
-6.00%
13.15
LMN
+0.38%

FAQ

What Is the Xlife Sciences (XLS) Stock Price Today?

The Xlife Sciences stock price today is 17.60 CHF.

What Stock Exchange Does Xlife Sciences Trade On?

Xlife Sciences is listed and trades on the Switzerland Stock Exchange.

What Is the Stock Symbol for Xlife Sciences?

The stock symbol for Xlife Sciences is "XLS."

What Is the Xlife Sciences Market Cap?

As of today, Xlife Sciences market cap is 100.36M CHF.

What Is Xlife Sciences's Earnings Per Share (TTM)?

The Xlife Sciences EPS (TTM) is -3.76.

From a Technical Analysis Perspective, Is XLS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Xlife Sciences Stock Split?

Xlife Sciences has split 0 times.

How Many Employees Does Xlife Sciences Have?

Xlife Sciences has 20 employees.

What is the current trading status of Xlife Sciences (XLS)?

As of Jul 16, 2026, Xlife Sciences (XLS) is trading at a price of 17.60 CHF, with a previous close of 17.80 CHF. The stock has fluctuated within a day range of 17.60 CHF to 17.60 CHF, while its 52-week range spans from 15.75 CHF to 26.80 CHF.

What Is Xlife Sciences (XLS) Price Target According to Analysts?

The average 12-month price target for Xlife Sciences is 50.00 CHF, with a high estimate of 50 CHF and a low estimate of 50 CHF. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +184.09% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.